Prevention of upper respiratory tract infections by gargling: a randomized trial
- PMID: 16242593
- DOI: 10.1016/j.amepre.2005.06.013
Prevention of upper respiratory tract infections by gargling: a randomized trial
Abstract
Background: Gargling to wash the throat is commonly performed in Japan, and people believe that such hygienic routine, especially with gargle medicine, prevents upper respiratory tract infections (URTIs). Its effectiveness, however, has not been established by clinical trials.
Design: Randomized controlled trial carried out in 2002-2003 winter season and analyzed in 2003 and 2004.
Participants: Healthy volunteers (387) aged 18 to 65 years.
Intervention: Participants were randomly assigned to water gargling, povidone-iodine gargling, and usual care (control). Subjects in the two gargling groups were requested to gargle with water or diluted povidone-iodine at least three times a day. Participants were followed for 60 days.
Main outcome measures: The primary outcome measure was first URTI incidence. Severity of URTI symptoms among incident cases was also evaluated. Both outcomes were assessed with a self-administered symptom record. Analyses were performed on an intention-to-treat basis.
Results: A total of 130 participants contracted URTIs. The incidence rate of first URTI was 0.26 episodes/30 person-days among control subjects. The rate decreased to 0.17 episodes/30 person-days in the water gargling group, and 0.24 episodes/30 person-days in the povidone-iodine gargling group. Respective incidence rate ratios against controls were 0.64 (95% confidence interval [CI]=0.41-0.99) and 0.89 (95% CI=0.60-1.33). A Cox regression (proportional hazard model) revealed the efficacy of water gargling (hazard ratio=0.60, 95% CI=0.39-0.95). Even when a URTI occurred, water gargling tended to attenuate bronchial symptoms (p=0.055).
Conclusions: Simple water gargling was effective to prevent URTIs among healthy people. This virtually cost-free modality would appreciably benefit the general population.
Similar articles
-
Cost-effectiveness of gargling for the prevention of upper respiratory tract infections.BMC Health Serv Res. 2008 Dec 16;8:258. doi: 10.1186/1472-6963-8-258. BMC Health Serv Res. 2008. PMID: 19087312 Free PMC article. Clinical Trial.
-
Gargling with povidone-iodine reduces the transport of bacteria during oral intubation.Can J Anaesth. 2004 Nov;51(9):932-6. doi: 10.1007/BF03018895. Can J Anaesth. 2004. PMID: 15525622 Clinical Trial.
-
Prevention of respiratory infections by povidone-iodine gargle.Dermatology. 2002;204 Suppl 1:32-6. doi: 10.1159/000057722. Dermatology. 2002. PMID: 12011518
-
Povidone iodine-induced overt hypothyroidism in a patient with prolonged habitual gargling: urinary excretion of iodine after gargling in normal subjects.Intern Med. 2007;46(7):391-5. doi: 10.2169/internalmedicine.46.1899. Epub 2007 Apr 2. Intern Med. 2007. PMID: 17409604 Review.
-
Could antiseptic gargling prevent COVID-19?Trop Biomed. 2020 Dec 1;37(4):1141-1145. doi: 10.47665/tb.37.4.1141. Trop Biomed. 2020. PMID: 33612766 Review.
Cited by
-
The effects of mouth rinsing and gargling with mouthwash containing povidone-iodine and hydrogen peroxide on the cycle threshold value of Severe Acute Respiratory Syndrome Coronavirus 2: A randomized controlled trial of asymptomatic and mildly symptomatic patients.F1000Res. 2024 Jul 1;11:1238. doi: 10.12688/f1000research.110843.2. eCollection 2022. F1000Res. 2024. PMID: 38988895 Free PMC article. Clinical Trial.
-
Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection.Cochrane Database Syst Rev. 2020 Sep 16;9(9):CD013626. doi: 10.1002/14651858.CD013626.pub2. Cochrane Database Syst Rev. 2020. PMID: 32936949 Free PMC article.
-
Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial.Sci Rep. 2021 Oct 7;11(1):19937. doi: 10.1038/s41598-021-99013-5. Sci Rep. 2021. PMID: 34620904 Free PMC article. Clinical Trial.
-
Effects of orally administered lactoferrin and lactoperoxidase on symptoms of the common cold.Int J Health Sci (Qassim). 2018 Sep-Oct;12(5):44-50. Int J Health Sci (Qassim). 2018. PMID: 30202407 Free PMC article.
-
Unintended beneficial effects of COVID-19 on influenza-associated emergency department use in Korea.Am J Emerg Med. 2022 Sep;59:1-8. doi: 10.1016/j.ajem.2022.06.039. Epub 2022 Jun 26. Am J Emerg Med. 2022. PMID: 35772222 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical